Search results

309 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Advocates join together to raise awareness about pancreatic cancer
When scientists and advocates join forces, good things can happen. Dr. Channing Der, Sarah Graham Kenan Professor of Pharmacology and UNC Lineberger faculty member, and Lori Matteson, a Raleigh pancreatic cancer survivor and advocate, joined over 600 other pancreatic cancer advocates and family members on a visit to Washington, DC.
Located in News / 2012 News
Rathmell, Yang honored with Hettleman awards
Located in News / 2012 News
Working on workplace wellness, Linnan featured in an expert interview
An expert interview with Laura Linnan, ScD, CHES, is featured in News & Views, a publication of the Wellness Council of America (WELCOA).
Located in News / 2011 News
ESPN anchor Stuart Scott featured speaker at Fast Break Against Cancer
Seventh annual event benefits cancer research and treatment in our community
Located in News / 2011 News
Testicular cancer treatment, one patient's story
UNC Lineberger patient David Alston talks about the treatment he is undergoing for testicular cancer.
Located in News / 2012 News
Grant to fund use of kinase test in HER2-positive breast cancer
Chapel Hill, NC – Susan G. Komen for the Cure® has awarded a grant of almost $900,000 to Lisa A. Carey, MD, and Gary Johnson, PhD, to research clinical applications for the first broad-based test for protein kinase activation and response to inhibitory drugs in HER2-positive breast cancer.
Located in News / 2012 News
Todd Auman, PhD, appointed director of UNC Lineberger’s Tissue Procurement Facility
Todd Auman, PhD, has been appointed director of UNC Lineberger Comprehensive Cancer Center’s Tissue Procurement Facility.
Located in News / 2012 News
Science, surgery, and start-ups - in depth with Dr. Nancy DeMore
UNC surgeon-scientist Dr. Nancy DeMore says, “As a physician, I’m acutely aware of how much more we need to learn about breast cancer and how urgently we need better therapies. It really gives me hope to be in the lab and to know that I’m working towards something that may make things better for patients.”
Located in News / 2012 News
Protein complex affects cells’ ability to move, respond to external cues
Chapel Hill, NC – In a paper published today in the journal, Cell, a team from the University of North Carolina at Chapel Hill has explained for the first time how a long-studied protein complex affects cell migration and how external cues affect cell’s ability to migrate.
Located in News / 2012 News
UNC study shows potential for nanotechnology-based therapy for ovarian cancer
Chapel Hill - A UNC-led study has shown the potential for nanotechnology therapy for ovarian cancer. Scientists at UNC Lineberger Comprehensive Cancer Center and Duke University Medical Center conducted a preclinical study using nanoparticle technology to deliver doses of chemo- and radiotherapy that specifically targeted metastasized ovarian cancer cells, eradicating the cancer and lessening the toxicities often associated with the treatment.
Located in News / 2011 News